Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 162

Sort by

Sort Order Select

Journal Articles

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Blood (2015) 126 (23): 5205.

https://doi.org/10.1182/blood.V126.23.5205.5205

Published: 2015

Journal Articles

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Vikas Madan, PhD, Deepika Kanojia, PhD, Li Jia, Ryoko Okamoto, PhD, Aiko Sato-Otsubo, Alexander Kohlmann, PhD, Masashi Sanada, MD PhD, Vera Grossmann, Janani Sundaresan, Yuichi Shiraishi, PhD, Satoru Miyano, PhD, Felicitas Thol, MD, Arnold Ganser, Henry Yang, PhD, Torsten Haferlach, Seishi Ogawa, MD PhD, H. Phillip Koeffler

Blood (2014) 124 (21): 4609.

https://doi.org/10.1182/blood.V124.21.4609.4609

Published: 2014

Journal Articles

Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients

Silvia Salmoiraghi, BiolSc, Greta Ubiali, BiolSc, Manuela Tosi, BiolSc, Barbara Peruta, BiolSc, Marie Lorena Guinea Montalvo, BiolSc, Elena Oldani, BiolSc, Cristina Boschini, MSc, Alexander Kohlmann, PhD, Sabina Chiaretti, Tamara Intermesoli, MD, Renato Bassan, MD, Orietta Spinelli, PhD, Alessandro Rambaldi

Blood (2014) 124 (21): 3796.

https://doi.org/10.1182/blood.V124.21.3796.3796

Published: 2014

Journal Articles

TP53 mutations occur in 15.7% of ALL and are associated with MYC -rearrangement, low hypodiploidy, and a poor prognosis

Anna Stengel, Susanne Schnittger, Sandra Weissmann, Sabrina Kuznia, Wolfgang Kern, Alexander Kohlmann, Torsten Haferlach, Claudia Haferlach

Blood (2014) 124 (2): 251–258.

https://doi.org/10.1182/blood-2014-02-558833

Published: 2014

Includes: Supplemental data

Journal Articles

Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis

Blood (2014) 123 (14): 2229–2237.

https://doi.org/10.1182/blood-2013-11-538025

Published: 2014

Includes: Supplemental data

Journal Articles

Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients

Nicolas Rapin, Frederik Otzen Bagger, Johan Jendholm, Helena Mora-Jensen, Anders Krogh, Alexander Kohlmann, Christian Thiede, Niels Borregaard, Lars Bullinger, Ole Winther, Kim Theilgaard-Mönch, Bo T. Porse

Blood (2014) 123 (6): 894–904.

https://doi.org/10.1182/blood-2013-02-485771

Published: 2014

Includes: Supplemental data

Journal Articles

Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis

Blood (2013) 122 (21): 2622.

https://doi.org/10.1182/blood.V122.21.2622.2622

Published: 2013

Journal Articles

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Alexander Kohlmann, PhD, Andreas Roller, PhD, Jennifer Kienast, Sabine Denzel, PhD, Vera Grossmann, PhD, Niroshan Nadarajah, MSc, Tamara Alpermann, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 2998.

https://doi.org/10.1182/blood.V122.21.2998.2998

Published: 2013

Journal Articles

Cooperativity Of RUNX1 and CSF3R Mutations In The Development Of Leukemia In Severe Congenital Neutropenia: A Unique Pathway In Myeloid Leukemogenesis

Blood (2013) 122 (21): 444.

https://doi.org/10.1182/blood.V122.21.444.444

Published: 2013

Journal Articles

Myelodysplastic Syndromes (MDS) With 20q Deletion Show a High Frequency Of Associated Cytogenetic and Molecular Lesions With An Association To U2AF1 , SRSF2 , and Prognostically Adverse ASXL1 Mutations

Ulrike Bacher, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD, Melanie Zenger, Manja Meggendorfer, PhD, Andreas Roller, PhD, Vera Grossmann, PhD, Maria Theresa Krauth, MD, Sabine Jeromin, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 657.

https://doi.org/10.1182/blood.V122.21.657.657

Published: 2013

Journal Articles

The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories

Blood (2013) 122 (21): 743.

https://doi.org/10.1182/blood.V122.21.743.743

Published: 2013

Journal Articles

TP53 Mutations Are Present In 15.7% Of ALL, Are Especially Frequent In ALL With MYC -Rearrangement and In ALL With Low Hypodiploid Chromosome Status and Are Associated With Poor Prognosis

Claudia Haferlach, MD, Sandra Weissmann, PhD, Sabrina Kuznia, MSc, Susanne Schnittger, PhD, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 827.

https://doi.org/10.1182/blood.V122.21.827.827

Published: 2013

Journal Articles

TP53 Alterations In CLL - Parameters Influencing The Prognostic Impact: A Study On 3,988 Patients

Claudia Haferlach, MD, Frank Dicker, PhD, Sabine Jeromin, PhD, Sandra Weissmann, PhD, Andreas Roller, PhD, Wenke Worseg, Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach, MD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 865.

https://doi.org/10.1182/blood.V122.21.865.865

Published: 2013

Journal Articles

A 13-Gene Panel Targeted To Investigate CLL By Next-Generation Amplicon Deep-Sequencing Can Be Successfully Implemented In Routine Diagnostics

Alexander Kohlmann, PhD, Andreas Roller, PhD, Andreia Albuquerque, PhD, Sabrina Kuznia, MSc, Sandra Weissmann, PhD, Sabine Jeromin, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2013) 122 (21): 867.

https://doi.org/10.1182/blood.V122.21.867.867

Published: 2013

Journal Articles

Analysis For Loss Of 13q Heterozygosity Using STR Or SNP Analysis Can Replace Analysis Of FLT3 -ITD To Detect Prognostically Adverse AML

Susanne Schnittger, PhD, Simone Weber, Sonja Schindela, Andreas Roller, PhD, Tamara Alpermann, Alexander Kohlmann, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2013) 122 (21): 805.

https://doi.org/10.1182/blood.V122.21.805.805

Published: 2013

Journal Articles

Further Insights Into The Molecular Landscape Of De Novo Acute Myeloid Leukemia (AML) Investigating 1,291 Patients

Torsten Haferlach, MD, Ulrike Bacher, MD, Tamara Alpermann, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Susanne Schnittger, PhD, Claudia Haferlach, MD

Blood (2013) 122 (21): 607.

https://doi.org/10.1182/blood.V122.21.607.607

Published: 2013

Journal Articles

Tyrosine Kinase Inhibitor Treated CML Patients Harboring Philadelphia-Negative Cytogenetically Aberrant Clones Show Molecular Mutations In 31% Of Cases Not Present At Diagnosis: A High-Throughput Amplicon Sequencing Study Of 29 Genes

Susanne Schnittger, PhD, Sabrina Kuznia, MSc, Manja Meggendorfer, PhD, Niroshan Nadarajah, MSc, Sabine Jeromin, PhD, Tamara Alpermann, Andreas Roller, PhD, Andreia Albuquerque, PhD, Sandra Weissmann, PhD, Thomas Ernst, Christiane Eder, PhD, Frank Dicker, PhD, Wolfgang Kern, MD, Alexander Kohlmann, PhD, Torsten Haferlach, MD, Andreas Hochhaus, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 611.

https://doi.org/10.1182/blood.V122.21.611.611

Published: 2013

Journal Articles

Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency

Verena Patterer, PhD, Melanie Zenger, Susanne Schnittger, PhD, Sandra Weissmann, PhD, Franziska Poetzinger, Alexander Kohlmann, PhD, Frauke Bellos, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 615.

https://doi.org/10.1182/blood.V122.21.615.615

Published: 2013

Journal Articles

Mutational Complexity Is Related To Disease Severity In Systemic Mastocytosis

Blood (2013) 122 (21): 4094.

https://doi.org/10.1182/blood.V122.21.4094.4094

Published: 2013

Journal Articles

MDS-Derived Stromal Cells Exhibit Altered Gene Expression and Support The Engraftment Of lin - CD34 + CD38 - Disease-Initiating Stem Cells In a Xenograft Model Of Lower Risk MDS

Blood (2013) 122 (21): 100.

https://doi.org/10.1182/blood.V122.21.100.100

Published: 2013

NARROW

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

ZRSR2 Mutations Cause Dysregulated RNA Splicing in MDS

Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients

TP53 mutations occur in 15.7% of ALL and are associated with MYC -rearrangement, low hypodiploidy, and a poor prognosis

Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis

Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients

Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis

Deep-Sequencing Of The Molecular Landscape In Burkitt Lymphoma/Leukemia

Cooperativity Of RUNX1 and CSF3R Mutations In The Development Of Leukemia In Severe Congenital Neutropenia: A Unique Pathway In Myeloid Leukemogenesis

Myelodysplastic Syndromes (MDS) With 20q Deletion Show a High Frequency Of Associated Cytogenetic and Molecular Lesions With An Association To U2AF1 , SRSF2 , and Prognostically Adverse ASXL1 Mutations

The Interlaboratory Robustness Of Next-Generation Sequencing (IRON) Study Phase II: Deep-Sequencing Analyses Of Hematological Malignancies Performed In 8,867 Cases By An International Network Involving 27 Laboratories

TP53 Mutations Are Present In 15.7% Of ALL, Are Especially Frequent In ALL With MYC -Rearrangement and In ALL With Low Hypodiploid Chromosome Status and Are Associated With Poor Prognosis

TP53 Alterations In CLL - Parameters Influencing The Prognostic Impact: A Study On 3,988 Patients

A 13-Gene Panel Targeted To Investigate CLL By Next-Generation Amplicon Deep-Sequencing Can Be Successfully Implemented In Routine Diagnostics

Analysis For Loss Of 13q Heterozygosity Using STR Or SNP Analysis Can Replace Analysis Of FLT3 -ITD To Detect Prognostically Adverse AML

Further Insights Into The Molecular Landscape Of De Novo Acute Myeloid Leukemia (AML) Investigating 1,291 Patients

Tyrosine Kinase Inhibitor Treated CML Patients Harboring Philadelphia-Negative Cytogenetically Aberrant Clones Show Molecular Mutations In 31% Of Cases Not Present At Diagnosis: A High-Throughput Amplicon Sequencing Study Of 29 Genes

Acute Lymphoblastic Leukemia (ALL) With Low-Hypodiploid/Near-Triploid Karyotype Is a Specific Clinical Entity Characterized By a High TP53 Mutation Frequency

Mutational Complexity Is Related To Disease Severity In Systemic Mastocytosis

MDS-Derived Stromal Cells Exhibit Altered Gene Expression and Support The Engraftment Of lin - CD34 + CD38 - Disease-Initiating Stem Cells In a Xenograft Model Of Lower Risk MDS

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only